📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nereus Pharmaceuticals

1.1 - Company Overview

Nereus Pharmaceuticals Logo

Nereus Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapeutics discovery and development focused on oncology, infectious diseases, and inflammation, leveraging marine microbiology technologies to identify and develop drug candidates, including NPI-2358, a tumor vascular disrupting agent.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nereus Pharmaceuticals

Lightpoint Medical Logo

Lightpoint Medical

HQ: United Kingdom Website
  • Description: Provider of intraoperative imaging technology for real-time cancer detection during surgery, including Cerenkov Luminescence Imaging (CLI) to reduce recurrence and reoperation; offers SENSEI®, a miniature gamma probe for minimally-invasive and robot-assisted procedures to detect radiation and guide surgeons.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lightpoint Medical company profile →
IO Biotech Logo

IO Biotech

HQ: Denmark Website
  • Description: Provider of immune-modulating cancer therapies built on its T-win technology, activating T cells against tumor and immune-suppressive cells. Offers IO102-IO103 T-win vaccines targeting IDO and PD-L1, used with anti-PD-1 therapy for metastatic melanoma, and runs Phase 2/3 trials with pembrolizumab in melanoma, lung, head and neck, and bladder cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IO Biotech company profile →
Enara Bio Logo

Enara Bio

HQ: United Kingdom Website
  • Description: Provider of cancer immunotherapy solutions targeting the T-cell/cancer cell interface, offering the EDAPT platform to discover cancer-specific Dark Antigens, TCR-directed immunotherapies, and off-the-shelf therapeutic cancer vaccines targeting multiple Dark Antigens for broad patient populations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enara Bio company profile →
U3 Pharma Logo

U3 Pharma

HQ: Germany Website
  • Description: Provider of targeted cancer drug development and novel targeted therapeutics, based in Martinsried near Munich, Germany. Established in 2001, U3 Pharma develops a pipeline of targeted therapies grounded in discoveries by founder Professor Axel Ullrich. Since May 2008, the company has belonged to DAIICHI Sankyo Co., Ltd.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full U3 Pharma company profile →
CoStim Logo

CoStim

HQ: United States Website
  • Description: Provider of antibody agents for cancer treatment and urban regeneration, construction, energy, and digital solutions, including the ChorusLife smart human district, general contracting (Impresa Percassi), construction envelope design and manufacturing (Gualini), global energy services (Elmet), and the GSM Platform for sustainable urban transformation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CoStim company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nereus Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nereus Pharmaceuticals

2.2 - Growth funds investing in similar companies to Nereus Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nereus Pharmaceuticals

4.2 - Public trading comparable groups for Nereus Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nereus Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nereus Pharmaceuticals

What does Nereus Pharmaceuticals do?

Nereus Pharmaceuticals is a provider of therapeutics discovery and development focused on oncology, infectious diseases, and inflammation, leveraging marine microbiology technologies to identify and develop drug candidates, including NPI-2358, a tumor vascular disrupting agent.

Who are Nereus Pharmaceuticals's competitors?

Nereus Pharmaceuticals's competitors and similar companies include Lightpoint Medical, IO Biotech, Enara Bio, U3 Pharma, and CoStim.

Where is Nereus Pharmaceuticals headquartered?

Nereus Pharmaceuticals is headquartered in United States.

How many employees does Nereus Pharmaceuticals have?

Nereus Pharmaceuticals has 1,000 employees 🔒.

When was Nereus Pharmaceuticals founded?

Nereus Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Nereus Pharmaceuticals in?

Nereus Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nereus Pharmaceuticals

Who are the top strategic acquirers in Nereus Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Nereus Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nereus Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Nereus Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nereus Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Nereus Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Nereus Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nereus Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nereus Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nereus Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nereus Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nereus Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nereus Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Nereus Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nereus Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nereus Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nereus Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nereus Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nereus Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Nereus Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nereus Pharmaceuticals